ARTICLE | Clinical News
PNU 101387: Discontinue Phase II trials
March 26, 2001 8:00 AM UTC
Pharmacia Corp. (PHA), Peapack, N.J. Product: PNU 101387 Business: Neurological Therapeutic category: Receptor antagonist Target: Dopamine-4 receptor Description: Sonepiprazole Indication: Treat schi...